Author's reply. “Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment”

Meijide Míguez, Héctor; Montes García, Iñaki; Ochando Gómez, Miguel; García Merino, Isabel M; Cano, Emilio L; Torre, Alejandro De La.
Rev. esp. geriatr. gerontol. (Ed. impr.) ; 58(3): 175-175, may.-jun. 2023.
Artículo en Inglés | IBECS (España) | ID: ibc-221965

Documentos relacionados

  1. Association between Covid-19 vaccination, fear of COVID-19 and female sexual satisfaction among a sample of Lebanese women: A pilot study
  2. Autoimmune Hepatitis after AstraZeneca Coronavirus Disease 2019 (COVID-19) vaccine: need for epidemiological study
  3. COVID-19 vaccination, do women suffer from more side effects than men? A retrospective cross-sectional study
  4. Vulnerability to SARS-CoV-2 infection and disease: ripping the curl after the storm
  5. Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: A real-life study
  6. [Living with an ongoing crisis - insights from the coronavirus - SARS-CoV].
  7. Coronavirus: time to re-imagine academic publishing.
  8. Insights for COVID-19 in 2023
  9. Actualización de las recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (COVID-19) en pacientes con trasplante renal
  10. Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper